NCT04759105View on ClinicalTrials.gov

Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 3, 2019

Primary Completion Date

November 27, 2023

Study Completion Date

November 27, 2023

Conditions

Intervertebral Disc DegenerationChronic Low-back Pain

Interventions

DRUG

Autologous BM-MSC

intradiscal injection of autologous bone marrow mesenchymal stromal/stem cells

OTHER

Sham Procedure

anaesthesia, no disc injection, no placebo injection

Trial Locations (1)

00128

Campus Bio-Medico University of Rome, Roma

All Listed Sponsors

collaborator

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

collaborator

Center for Outcomes Research and Clinical Epidemiology, Italy

OTHER

lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER

NCT04759105 - Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD | Biotech Hunter | Biotech Hunter